| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/04/2007 | CN1990865A Method of treating endotoxemia |
| 07/04/2007 | CN1990487A Berberine ion pair compound, preparing method and drug containing same |
| 07/04/2007 | CN1990486A N-glycyl-pyrrolidine-2-nitrile and its use as DDP-IV enzyme inhibitor |
| 07/04/2007 | CN1990484A Silybin esters derivatives and preparation and use thereof |
| 07/04/2007 | CN1990482A Flavanonol compounds and their production method and use |
| 07/04/2007 | CN1990479A 3-alkoxy substituted-2, 5, 7-tri-substituted benzopyran-4-ketones compounds, preparing method thereof and pharmaceutical compounds containing same |
| 07/04/2007 | CN1990475A Substituted benzisoselenazolone compounds and use thereof |
| 07/04/2007 | CN1990470A Phthiobuzonum derivative, its manufacturing process, pharmaceutical combination and uses thereof |
| 07/04/2007 | CN1990469A Pyrrolidines as dipeptidyl peptidase inhibitors |
| 07/04/2007 | CN1990468A Pyrrolidines as dipeptidyl peptidase inhibitors |
| 07/04/2007 | CN1990457A 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 07/04/2007 | CN1990452A Process to produce a protease inhibitor |
| 07/04/2007 | CN1990043A Use of recombinant human granulocyte macrophagocyte colony stimulating factor in preparation of drug for preventing and treating hepatitis B |
| 07/04/2007 | CN1990042A SARS coronary virus resistant cell vaccine and its uses |
| 07/04/2007 | CN1990041A Kidney syndrome hemorrhagic fever Vero cell bivalent purified vaccine and industrialized producing process thereof |
| 07/04/2007 | CN1990037A Thymosin alpha1 active fragment and polyethylene glycol derivative thereof |
| 07/04/2007 | CN1990032A Composite intravenous injection emulsion of glossy ganoderma spore oil and coix seed oil and method for making same |
| 07/04/2007 | CN1990029A Medicinal composition for treating hepatic disease |
| 07/04/2007 | CN1990008A Chinese medicinal preparation with heat-clearing toxin-removing function and its preparation process |
| 07/04/2007 | CN1990007A Composition for treating stomachache, its preparation method and uses |
| 07/04/2007 | CN1990006A Chenopodium ambrosioides extract, preparation thereof, preparation method and use thereof |
| 07/04/2007 | CN1989996A Bear gall drop-pill and its preparation method |
| 07/04/2007 | CN1989989A Use of laggera plant abstract in inhibiting herpes simplex virus and hepatitis B virus |
| 07/04/2007 | CN1989982A Sterilizing therapeutic agent for pet acariasis |
| 07/04/2007 | CN1989979A Bee glue salicylic acid gel and its preparing process |
| 07/04/2007 | CN1989977A Effective medicinal powder for treating athlete's foot |
| 07/04/2007 | CN1989976A Effective therapeutic agent for ringworm of the nails |
| 07/04/2007 | CN1989970A Fungicidal active compound combinations |
| 07/04/2007 | CN1989966A Pharmaceutical composition comprising rifamoin and isoniazid |
| 07/04/2007 | CN1989965A Palmatine colon positoning agent and its preparation and usage |
| 07/04/2007 | CN1989963A Pharmaceutical compositions |
| 07/04/2007 | CN1989960A Andrographolide dispersed tablet |
| 07/04/2007 | CN1989959A Naphthoquinone compound and use of pharmaceutical composition thereof |
| 07/04/2007 | CN1989947A Process for the manufacture of particles containing antibotics and their application |
| 07/04/2007 | CN1324215C Emergency door opening system |
| 07/04/2007 | CN1324139C Vaccines |
| 07/04/2007 | CN1324046C Protein and sugar binding protein with anti-HIV activity |
| 07/04/2007 | CN1324034C Dioxazole pyrimidine nucleotide compounds with function of releasing NO and its use in pharmaceutics |
| 07/04/2007 | CN1324026C Process for preparing berberine sulphate |
| 07/04/2007 | CN1324025C Tropane derivatives as CCR5 modulators |
| 07/04/2007 | CN1324009C Pharmaceutical use of 1-N-methoxy-2-oxo-indole-3-acetamide |
| 07/04/2007 | CN1324001C Novel thyroid receptor ligands |
| 07/04/2007 | CN1323722C Positional isomers of PEG IFN alpha 2a |
| 07/04/2007 | CN1323718C Process for preparing viral and bacterial vaccine for animals utilizing vegetable oil adjuvant |
| 07/04/2007 | CN1323717C Buccal tablet of recombined human interferon alpha 1 b and its preparation |
| 07/04/2007 | CN1323707C Composition for treating and/or relaxing SARS and SARS kind syndrome |
| 07/04/2007 | CN1323695C Strong-effect external-applied preparation for treating multiple skin diseases |
| 07/04/2007 | CN1323680C Medicine for treating monilia vaginitis |
| 07/04/2007 | CN1323668C Pharmaceutical compositions and its application |
| 07/04/2007 | CN1323660C Medicament for the treatment of viral skin and tumour diseases |
| 07/04/2007 | CN1323585C Anti-pathogenic composition useful in blood preservation |
| 07/03/2007 | US7238811 Chemical compounds |
| 07/03/2007 | US7238716 Alkanoic acid derivatives process for their production and use thereof |
| 07/03/2007 | US7238703 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists |
| 07/03/2007 | US7238695 Imidazolyl derivatives |
| 07/03/2007 | US7238694 Rifamycin imino derivatives effective against drug-resistant microbes |
| 07/03/2007 | US7238685 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating vasoconstriction, proliferation and inflammation |
| 07/03/2007 | US7238684 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 07/03/2007 | US7238677 Prevention of urogenital infections |
| 07/03/2007 | US7238675 consisting of a substantially uncharged antisense oligomer with ratio of uncharged linkages to charged linkages in the oligomer is at least 4:1, preferably at least 5:1, and more preferably at least 8:1 |
| 07/03/2007 | US7238666 Method of inhibiting fibrosis with a somatostatin agonist |
| 07/03/2007 | US7238658 Treating agonist disorders including obesity, and hyperglycemic, whole body growth, immunological, kidney, neurological and neuromuscular disorders by administering a crystal of an insulin-like growth factor-1 that diffracts x-ray radiation to produce a three-dimensional diffraction pattern |
| 07/03/2007 | US7238489 Identification of sortase gene |
| 07/03/2007 | US7238481 administering HETEROLOGOUS GENE PRODUCTS IN HOST CELL SYSTEMS AND/OR TO RESCUE NEGATIVE STRAND RNA RECOMBINANT VIRUSES |
| 07/03/2007 | US7238358 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 07/03/2007 | US7238349 Composition |
| 07/03/2007 | CA2370685C Endoprosthesis with long-term stability |
| 07/03/2007 | CA2359177C Bhv-1 gene-deleted virus vaccine |
| 07/03/2007 | CA2350884C Topical compositions comprising ascomycins |
| 07/03/2007 | CA2252465C Urea derivatives as inhibitors of impdh enzyme |
| 07/03/2007 | CA2244662C Antifungal agents |
| 07/03/2007 | CA2212168C Antimicrobial composition composed of controlled release glasses |
| 07/03/2007 | CA2174122C Therapeutic delivery compositions and methods of use thereof |
| 06/28/2007 | WO2007073168A1 Carbamate antibiotics |
| 06/28/2007 | WO2007073112A1 A composition comprising azole antifungal drug and a preparation process thereof |
| 06/28/2007 | WO2007072916A1 Vaccine for in ovo inoculation |
| 06/28/2007 | WO2007072869A1 Amorphous form of 1,2-dihydropyridine compound |
| 06/28/2007 | WO2007072868A1 Crystal of 1,2-dihydropyridine compound (type iv) |
| 06/28/2007 | WO2007072866A1 Anti-ilt7 antibody |
| 06/28/2007 | WO2007072851A1 Process for production of water-soluble azole prodrug |
| 06/28/2007 | WO2007072697A1 Bactericidal water, method of producing the same and apparatus for producing the same |
| 06/28/2007 | WO2007072503A2 Combinations for managing inflammation and associated disorders |
| 06/28/2007 | WO2007072179A2 Histone deacetylase inhibitors for enhancing activity of antifungal agents |
| 06/28/2007 | WO2007072151A1 8-pyrazinyl-s-spiropyrimidinetrione-oxazinoquinoline derivatives as antibacterial agents |
| 06/28/2007 | WO2007072032A2 Neisseria meningitidis vaccines and their use |
| 06/28/2007 | WO2007072022A2 Composition comprising an antigen-recognizing molecule and a lipid-based carrier |
| 06/28/2007 | WO2007071936A1 Heterocyclic compounds, their preparation and their use as antibacterials |
| 06/28/2007 | WO2007071710A2 Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates |
| 06/28/2007 | WO2007071658A2 Alkyl phospholipid derivatives with reduced cytotoxicity and uses thereof |
| 06/28/2007 | WO2007071646A1 Novel substituted pyrazinone derivatives for use in mch-1 mediated diseases |
| 06/28/2007 | WO2007071453A1 Organophosphoric derivatives useful as anti-parasitic agents |
| 06/28/2007 | WO2007071159A1 The use of anthraquinone derivatives for preparation of medicaments against influenza and “bird flu” viruse |
| 06/28/2007 | WO2007071071A1 Oligonucleotides and antiviral uses thereof |
| 06/28/2007 | WO2007070985A1 Tiglien-3-one derivatives |
| 06/28/2007 | WO2007070984A1 Spiroketals |
| 06/28/2007 | WO2007070947A1 Antibacterial agents |
| 06/28/2007 | WO2007044756A3 Monoclonal antibodies recognizing human ccr8 |
| 06/28/2007 | WO2007018843A3 Methods and compositions for diagnosis and treatment of influenza |
| 06/28/2007 | WO2007005531A3 Alkenyldiarylmethanes, fused analogs and syntheses thereof |
| 06/28/2007 | WO2007002912A3 Anti-proliferative compounds, compositions, and methods of use thereof |